• SoftBank Vision Fund entities SVF Pauling (Cayman), SoftBank Vision Fund (AIV M2), SB Investment Advisers sold 6 million Relay Therapeutics common shares.
• Sale priced at USD 19.4 per share on Aug. 25, 2026.
• Beneficial ownership fell to 21,904,963 shares following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Relay Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-040513), on August 28, 2026, and is solely responsible for the information contained therein.